GlassScriptPhysician profile
Allison I Polender
NPI 1154521995
$3,518.12
in general payments reported to CMS, 2019-2025
40 companies · $448 in 2025
The $448 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $364 · 2021: $577 · 2022: $909 · 2023: $468 · 2024: $353 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,255 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,255.26 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $563.14 | 2019-2023 | |
| Hologic Sales and Service, LLC | $313.22 | 2021-2025 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Coloplast Corp | $228.97 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $204.59 | 2022-2025 | |
| Sage Therapeutics, LLC | $200.77 | 2021-2025 | Zurzuvae |
| Astellas Pharma US INC | $196.12 | 2023-2025 | Veozah |
| Gynesonics, INC. | $188.69 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $157.72 | 2019-2025 | |
| Therapeuticsmd, INC. | $143.44 | 2019-2022 | |
| Daiichi Sankyo INC. | $117.93 | 2020-2023 | Injectafer |
| Avion Pharmaceuticals | $107.08 | 2020-2023 | Balcoltra |
| Evofem Biosciences, INC. | $97.63 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $87.35 | 2019-2022 | |
| Exeltis, USA INC. | $81.27 | 2020-2025 | Slynd |
| Coopersurgical, INC. | $75.79 | 2019-2024 | Paragard T 380a, Paragard T 380a |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $74.00 | 2019 | |
| Organon LLC | $68.95 | 2022-2024 | Nexplanon |
| Dysis Medical, INC. | $65.52 | 2020 | |
| Amag Pharmaceuticals, INC. | $52.25 | 2019 | |
| Axonics, INC. | $45.90 | 2020-2021 | |
| Shield Therapeutics INC | $42.91 | 2023-2024 | Accrufer |
| Amgen INC. | $39.21 | 2019-2023 | |
| Myovant Sciences INC. | $37.09 | 2021 | |
| Merck Sharp & Dohme LLC | $36.89 | 2020-2021 | |
| Novo Nordisk INC | $33.35 | 2025 | Wegovy |
| Pacira Pharmaceuticals Incorporated | $30.96 | 2021-2023 | Exparel |
| Baxter Healthcare | $30.82 | 2023 | |
| Channel Medsystems, INC. | $26.73 | 2023 | |
| Pfizer INC. | $17.37 | 2022 | |
| Medicem INC. | $15.88 | 2021 | |
| Zyla Life Sciences, INC. | $15.43 | 2020 | |
| Meditrina | $15.33 | 2023 | |
| Ascend Therapeutics US, LLC | $14.44 | 2024 | |
| Boston Scientific Corporation | $14.43 | 2023 | |
| Ethicon US, LLC | $14.39 | 2022 | |
| Vertical Pharmaceuticals, LLC | $13.68 | 2019 | |
| Sumitomo Pharma America, INC. | $13.47 | 2025 | Myfembree |
| Agile Therapeutics, INC. | $12.04 | 2021 | |
| Roche Diagnostics Corporation | $11.97 | 2019 | |
| Millicent US INC | $11.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Polender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.